Enzychem Lifesciences Corporation (KOSDAQ:183490)

Enzychem Lifesciences Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	24,923	7,841	10,304	15,470	7,683	2,784
Short-Term Investments	68,951	84,979	106,771	121,604	185,173	91,803
Trading Asset Securities	-	-	-	276	-	-
Cash & Short-Term Investments	93,874	92,821	117,075	137,350	192,856	94,587
Cash Growth	-16.39%	-20.72%	-14.76%	-28.78%	103.89%	4.51%
Accounts Receivable	5,977	3,933	8,022	11,625	6,358	5,206
Other Receivables	4,981	295.59	513.16	1,425	3,428	661.09
Receivables	16,898	9,405	17,643	20,207	10,312	5,986
Inventory	22,013	11,879	12,113	14,946	9,794	8,355
Prepaid Expenses	546.92	300.92	78.09	134.77	73.65	169.68
Other Current Assets	2,810	1,369	1,321	1,837	7,277	685.8
Total Current Assets	136,142	115,774	148,230	174,475	220,313	109,783
Property, Plant & Equipment	13,063	19,149	24,160	26,164	23,294	15,431
Long-Term Investments	2,003	977.73	975.89	1,574	476.43	486.51
Goodwill	10,416	1,521	1,480	1,480	-	-
Other Intangible Assets	3,594	2,291	3,724	4,371	2,186	6,469
Long-Term Deferred Tax Assets	54.08	29.88	612.97	571.39	-	-
Long-Term Deferred Charges	48.61	64.81	-	-	0	-
Other Long-Term Assets	2,288	2,005	2,536	2,859	1,233	884.1
Total Assets	168,115	148,592	181,744	211,546	247,555	133,084

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	3,978	1,348	2,514	6,493	1,496	2,250
Accrued Expenses	148.46	5.76	7.97	10.21	59.78	16.12
Short-Term Debt	2,739	3,000	3,410	2,280	33,750	45,629
Current Portion of Long-Term Debt	671.25	237.31	425	1,113	2,492	2,867
Current Portion of Leases	352.49	513.86	699.55	654.19	344.64	126.7
Current Income Taxes Payable	136.36	25.58	18.5	-	-	-
Other Current Liabilities	2,353	3,102	4,299	3,603	4,142	2,732
Total Current Liabilities	10,379	8,232	11,375	14,154	42,284	53,621
Long-Term Debt	7,827	914.14	-	1,025	683.32	3,175
Long-Term Leases	188.45	173.54	345	584.45	509.09	179.98
Pension & Post-Retirement Benefits	976.25	433.11	1,079	440.23	2,334	627.21
Long-Term Deferred Tax Liabilities	-	-	668.21	715.09	-	819.58
Other Long-Term Liabilities	83.25	72.3	6,795	0	0	0
Total Liabilities	19,454	9,825	20,261	16,919	45,811	58,422

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	42,533	42,533	42,533	42,533	42,144	4,166
Additional Paid-In Capital	106,652	108,957	108,957	108,431	309,804	194,149
Retained Earnings	-3,617	1,876	19,530	41,910	-151,053	-124,665
Treasury Stock	-	-15,976	-10,822	-	-	-
Comprehensive Income & Other	155.78	150.44	155.98	641.6	580.01	822.79
Total Common Equity	145,723	137,540	160,353	193,516	201,474	74,472
Minority Interest	2,938	1,227	1,130	1,111	-	-
Shareholders' Equity	148,662	138,767	161,483	194,627	201,744	74,662
Total Liabilities & Equity	168,115	148,592	181,744	211,546	247,555	133,084

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	11,778	4,839	4,880	5,657	37,779	51,977
Net Cash (Debt)	82,096	87,982	112,195	131,693	155,077	42,609
Net Cash Growth	-24.09%	-21.58%	-14.81%	-15.08%	263.95%	-10.18%
Net Cash Per Share	1037.65	1137.89	1370.30	1550.62	1967.48	843.86
Filing Date Shares Outstanding	84.64	74.87	79.62	85.07	84.29	49.99
Total Common Shares Outstanding	84.64	74.87	79.62	85.07	84.29	49.99
Working Capital	125,762	107,542	136,855	160,321	178,028	56,163
Book Value Per Share	1721.68	1837.07	2014.00	2274.90	2390.31	1489.80
Tangible Book Value	131,714	133,728	155,150	187,665	199,289	68,003
Tangible Book Value Per Share	1556.16	1786.15	1948.64	2206.12	2364.38	1360.38
Land	2,452	8,249	8,249	8,090	6,249	6,249
Buildings	8,495	8,495	9,855	9,883	9,055	6,092
Machinery	20,878	20,206	21,579	21,252	18,549	14,238
Construction In Progress	-	-	89	122.75	68.5	194.46

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 21, 2026

Data Sources Report a data error